Polymeric nanoparticles loaded with docetaxel achieve 94% tumour regression in triple-negative breast cancer
pH-responsive PLGA nanoparticles enable targeted intratumoral drug accumulation while significantly reducing systemic toxicity compared to free docetaxel administration.














